Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
THURSDAY, Nov. 29, 2018 -- A liquid biopsy using blood or cerebrospinal fluid (CSF) can effectively quantify changes in mutation levels among pediatric patients being treated for diffuse midline gliomas (DMGs), according to a study recently...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Glioma | Neurology | Pediatrics | Pharmaceuticals | Study